For episode 19 of the Ori Spotlight Podcast, Jason C. Foster is joined by Isabelle Rivière, Director of Cell Therapy and Cell Engineering Laboratory at the Memorial Sloan-Kettering Cancer Center (MSKCC), one of the world’s leading cancer centers. Isabelle has also recently joined Ori as our newest SAB member – we’re honored to have her supporting us in achieving our mission.
To this episode, Isabelle brings insights she has gathered from 25 years of experience within the cell and gene therapy industry. Isabelle is also a co-founder of Juno Therapeutics, a board member of the American Society of Gene and Cell Therapy (ASGCT), and past board member of the Alliance for Regenerative Medicine (ARM). Together, Jason and Isabelle explore the most significant barriers to treating patients at scale, how automated systems – to improve monitoring, recording and tracking could help make therapies more affordable, and the importance of industry partnerships to accelerate the development of therapies and implementation of new technologies.
Learn more about:
Isabelle Rivière
Ori Biotech Ltd 2022 © All rights reserved. Oribiotech is registered in England and Wales. Company registration 09757696.